Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors

Cutis. 2023 Sep;112(3):E17-E20. doi: 10.12788/cutis.0859.

Authors

Jordan L Bormann¹, Amy M Kerkvliet¹

Affiliation

¹ Dr. Bormann is from the University of Utah Health Dermatology, Salt Lake City. Dr. Kerkvliet is from the Department of Pathology, Sanford School of Medicine, University of South Dakota, Sioux Falls.

PMID: 37903392
DOI: 10.12788/cutis.0859

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Autoimmune Diseases*
Cholangiocarcinoma* / drug therapy
Dermatitis*
Humans
Melanoma* / pathology
Mitogen-Activated Protein Kinase Kinases / therapeutic use
Mutation
Protein Kinase Inhibitors / adverse effects
Proto-Oncogene Proteins B-raf / genetics

Substances

BRAF protein, human
Mitogen-Activated Protein Kinase Kinases
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf